tiprankstipranks
Trending News
More News >
Biodesix (BDSX)
NASDAQ:BDSX
US Market

Biodesix (BDSX) Financial Statements

Compare
349 Followers

Biodesix Financial Overview

Biodesix's market cap is currently $103.58M. The company's EPS TTM is $-0.49; its P/E ratio is -2.41; Biodesix is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $-1.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 88.50M$ 71.32M$ 49.09M$ 38.21M$ 54.51M
Gross Profit$ 0.00$ 55.75M$ 36.08M$ 24.06M$ 23.99M
Operating Income$ -27.87M$ -34.50M$ -41.34M$ -50.59M$ -40.94M
EBITDA$ -21.88M$ -29.22M$ -37.10M$ -51.53M$ -35.47M
Net Income$ -35.27M$ -42.93M$ -52.15M$ -65.45M$ -43.16M
Balance Sheet
Cash & Short-Term Investments$ 18.99M$ 26.25M$ 26.28M$ 43.09M$ 32.71M
Total Assets$ 87.48M$ 97.24M$ 99.10M$ 92.91M$ 76.10M
Total Debt$ 72.85M$ 61.98M$ 60.69M$ 31.85M$ 10.01M
Net Debt$ 53.87M$ 35.73M$ 34.41M$ -11.24M$ -22.70M
Total Liabilities$ 89.94M$ 76.37M$ 94.52M$ 72.30M$ 56.37M
Stockholders' Equity$ -2.46M$ 20.88M$ 4.58M$ 20.61M$ 19.73M
Cash Flow
Free Cash Flow$ -23.53M$ -51.88M$ -45.93M$ -48.51M$ -30.77M
Operating Cash Flow$ -23.27M$ -48.65M$ -22.87M$ -44.97M$ -28.22M
Investing Cash Flow$ -403.00K$ -3.44M$ -23.06M$ -3.53M$ -2.55M
Financing Cash Flow$ 16.42M$ 52.05M$ 29.13M$ 58.88M$ 1.26M
Currency in USD

Biodesix Earnings and Revenue History

Biodesix Debt to Assets

Biodesix Cash Flow

Biodesix Forecast EPS vs Actual EPS